当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析 - 资产负债表

海尔生物

(688139)

  

流通市值:90.52亿  总市值:90.52亿
流通股本:3.16亿   总股本:3.16亿

资产负债表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
流动资产:
  货币资金997,823,296.34973,449,794.97843,825,249.51691,844,623.72
  交易性金融资产553,592,622.53505,408,853.88447,591,068.5653,414,470.32
  衍生金融资产221,369.44178,944.33--
  应收票据及应收账款415,924,273.95512,325,267.13411,714,556.83439,846,071.91
  其中:应收票据5,156,083.126,883,837.477,292,980.638,857,425.96
        应收账款410,768,190.83505,441,429.66404,421,576.2430,988,645.95
  应收款项融资63,569,890.0312,881,171.1919,702,632.5713,366,860.05
  预付款项26,912,119.5828,026,403.8330,087,423.0433,162,032.3
  其他应收款合计7,923,992.888,018,789.888,050,329.97,688,434.94
  存货333,937,893.02337,105,155.33345,474,341.6316,654,053.99
  合同资产13,761,094.1213,707,92513,866,048.188,107,246.26
  一年内到期的非流动资产382,659,391.2339,776,836.79525,514,411.75373,680,826.88
  其他流动资产9,389,246.1110,510,796.9813,015,696.8912,313,030.61
  流动资产合计2,805,715,189.22,741,389,939.312,658,841,758.772,550,077,650.98
非流动资产:
  长期股权投资176,603,151.48189,056,364.98188,228,569.38187,238,645.78
  其他权益工具投资47,340,671.1452,108,10052,108,10040,206,222.54
  其他非流动金融资产17,808,475.9317,807,329.1217,807,329.1218,000,000
  投资性房地产7,704,695.977,896,857.218,089,018.478,281,179.72
  固定资产856,004,540.74865,612,064.66858,715,732.42862,519,384.29
  在建工程76,112,915.8465,144,555.4854,968,724.457,539,589.63
  使用权资产6,818,749.938,085,566.659,325,392.4810,064,262.46
  无形资产338,596,316.33349,904,645.93360,497,939.89369,914,583.78
  商誉757,719,546.74757,847,032.69758,242,562.84758,387,976.51
  长期待摊费用5,481,492.675,083,752.675,602,653.426,149,601.53
  递延所得税资产100,071,036.6494,016,181.2989,674,622.783,165,709.97
  其他非流动资产630,736,397.55701,754,897.67729,412,485.34698,899,615.25
  非流动资产合计3,020,997,990.963,114,317,348.353,132,673,130.463,100,366,771.46
  资产总计5,826,713,180.165,855,707,287.665,791,514,889.235,650,444,422.44
流动负债:
  短期借款10,005,208.3310,003,561.6410,007,123.2810,006,500
  应付票据及应付账款485,553,882.8460,004,224.55429,382,999.1415,356,450.33
  其中:应付票据121,529,360.28107,148,559.1694,913,195.96105,592,011.84
        应付账款364,024,522.52352,855,665.39334,469,803.14309,764,438.49
  合同负债105,004,598.45122,882,725.05170,918,330.5692,609,220.55
  应付职工薪酬69,346,419.5963,367,987.6182,614,116.7975,423,297.74
  应交税费32,632,288.3424,489,125.3744,425,054.4448,592,059.69
  其他应付款合计259,610,492.28290,979,411.86251,145,571.81255,233,126.45
  一年内到期的非流动负债80,917,177.4380,490,014.1180,595,123.421,799,306.42
  其他流动负债11,684,132.3516,270,553.516,401,943.917,272,677.14
  流动负债合计1,054,754,199.571,068,487,603.691,085,490,263.29926,292,638.32
非流动负债:
  租赁负债2,935,010.574,637,322.834,544,680.176,737,003.08
  长期应付款---57,283,117.64
  预计负债6,541,545.146,308,817.646,308,817.646,497,810.78
  递延收益50,339,157.2229,951,795.2926,084,497.2220,721,062.07
  递延所得税负债42,761,038.3544,247,209.9745,891,814.8147,536,844.02
  非流动负债合计102,576,751.2885,145,145.7382,829,809.84138,775,837.59
  负债合计1,157,330,950.851,153,632,749.421,168,320,073.131,065,068,475.91
所有者权益(或股东权益):
  实收资本(或股本)316,492,922316,492,922317,952,508317,952,508
  资本公积1,884,895,217.571,878,115,033.261,976,397,633.341,981,720,560.13
  减:库存股149,713,183.04150,041,011.44248,682,662.57231,888,823.98
  其他综合收益2,994,560.697,446,240.857,455,309.09-2,395,903.04
  盈余公积158,976,254158,976,254158,976,254158,976,254
  未分配利润2,207,775,778.052,243,058,864.422,163,598,018.232,111,258,117.99
  归属于母公司股东权益合计4,421,421,549.274,454,048,303.094,375,697,060.094,335,622,713.1
  少数股东权益247,960,680.04248,026,235.15247,497,756.01249,753,233.43
  股东权益合计4,669,382,229.314,702,074,538.244,623,194,816.14,585,375,946.53
  负债和股东权益合计5,826,713,180.165,855,707,287.665,791,514,889.235,650,444,422.44
公告日期2026-08-202026-04-302026-03-282025-10-31
审计意见(境内)标准无保留意见
TOP↑